{{Rsnum
|rsid=2605100
|Gene=LOC728510
|Chromosome=1
|position=219470882
|Orientation=plus
|GMAF=0.2199
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 7.1 | 48.7 | 44.2
| HCB | 3.6 | 29.2 | 67.2
| JPT | 2.8 | 22.9 | 74.3
| YRI | 0.0 | 13.6 | 86.4
| ASW | 1.8 | 19.3 | 78.9
| CHB | 3.6 | 29.2 | 67.2
| CHD | 3.7 | 29.4 | 67.0
| GIH | 5.0 | 28.0 | 67.0
| LWK | 1.8 | 18.3 | 79.8
| MEX | 17.5 | 33.3 | 49.1
| MKK | 5.2 | 33.5 | 61.3
| TSI | 8.8 | 40.2 | 51.0
| HapMapRevision=28
}}
{{PMID Auto GWAS
|PMID=19557161
|Trait=Adiposity
|Title=Genome-Wide Association Scan Meta-Analysis Identifies Three Loci Influencing Adiposity and Fat Distribution
|RiskAllele=G
|Pval=3E-8
|OR=0.04
|ORtxt=[0.03-0.05] z-score unit increase
|OA=1
}}

{{PMID Auto
|PMID=21686128
|Title=Novel abdominal adiposity genes and the risk of type 2 diabetes: findings from two prospective cohorts
|OA=1
}}

{{PMID Auto
|PMID=22179955
|Title=Genetic predictors of weight loss and weight regain after intensive lifestyle modification, metformin treatment, or standard care in the Diabetes Prevention Program.
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2605100
|overall_frequency_n=100
|overall_frequency_d=128
|overall_frequency=0.78125
|n_genomes=54
|n_genomes_annotated=0
|n_haplomes=87
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}